The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Open accessAbstract
The fibrillar peptide amyloid-beta (A beta) has a chief function in the pathogenesis of Alzheimer's disease. Interleukin 1 beta (IL-1 beta) is a key cytokine in the inflammatory response to A beta. Insoluble materials such as crystals activate the inflammasome formed by the cytoplasmic receptor NALP3, which results in the release of IL-1 beta. Here we identify the NALP3 inflammasome as a sensor of A beta in a process involving the phagocytosis of A beta and subsequent lysosomal damage and release of cathepsin B. Furthermore, the IL-1 beta pathway was essential for the microglial synthesis of proinflammatory and neurotoxic factors, and the inflammasome, caspase-1 and IL-1 beta were critical for the recruitment of microglia to exogenous A beta in the brain. Our findings suggest that activation of the NALP3 inflammasome is important for inflammation and tissue damage in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Based on the previous literature42,43,46, we reasoned that cathepsin B leaking from the destabilized lysosomes may mediate the NLRP3 inflammasome activation upon SHIP1 inhibition11.”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fibrillar Aβ (fAβ), following phagocytosis by microglia, activates the NLRP3 inflammasome and leads to increases in secretion of IL-1β and IL-18.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sustained elevations of IL-1β have been postulated to play a key role in AD pathogenesis [6, 12–14].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Halle et al. found that fibrillar Aβ can induce the secretion of IL-1β which depends on the presence of NLRP3.352,353”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [352]
The cited source says what the claim attributes to it.
In the citing paper
“lysosomal cathepsins, such as cathepsin B, can induce NLRP3 inflammasome activation upon leaking into the cytosol following lysosomal membrane permeabilization (LMP)42,43”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“fAβ phagocytosis results in lysosomal dysfunction and release of lysosomal contents into the cytoplasm, including the lysosomal protease cathepsin B, which is a mediator of inflammasome activation induced by Aβ [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In line with these findings, another study showed that aggregated tau seeds activated the NLRP3 inflammasome in primary mouse microglia by inducing lysosomal destabilization and release of the lysosomal protease cathepsin B, similar to fAβ [78, 82].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In parallel, reduction of SHIP1 activity is poised to disinhibit signaling pathways that are involved in the phagocytosis of Aβ, which is a required step for Aβ-induced activation of the NLRP3 inflammasome [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
In the citing paper
“Notably, Aβ also can activate NF-κB signaling and the NLRP3-ASC inflammasome [426, 427], suggesting that Aβ and tau share common mechanisms in microglia activation.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [426]
In the citing paper
“Following phagocytosis by microglia, Aβ activates the NLRP3 inflammasome leading to caspase-1 activation and IL-1β maturation and release (Halle et al., 2008).”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Halle et al., 2008
In the citing paper
“Fibrillar Aβ amyloids can induce the secretion of IL-1β from microglia, via the NLRP3 inflammasome (228, 249).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“Importantly, researchers also found that ASC-, caspase-1-, IL-1 receptor-, and MyD88-deficient mice had less recruitment of microglia and mononuclear phagocytes to Aβ in the brain as compared to the wild type control after the injection of Aβ into the striatum (228).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“NLRP3 has been shown to respond to sterile stimuli, including asbestos, silica, MSU and CPPD crystals55, cholesterol crystals and β-amyloid fibrils56.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“Furthermore, there is only partial inhibition of the neutrophil infiltration and IL-1β production associated with sterile inflammation in response to cholesterol crystals44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“However, cathepsin b-deficient macrophages have no impairment in IL-1β production in response to certain NLRP3 agonists, including LPS plus ATP, or MSU crystals, despite the impairment in their response to silica44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“evidence to support this are the observations that artificial lysosomal rupture alone can activate NLRP3 and that pharmacological inhibition or genetic depletion of cathepsin b results in inhibition of caspase 1 activation, although this inhibition was only partial44,56,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“In support of this, direct treatment of ATP on primed microglia is sufficient for maturation and release of IL-1β in vitro (Halle et al, 2008) and does so via the P2X 7 receptor (Colomar et al, 2003) expressed on microglia (Monif et al, 2009).”
From Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal (2017) · cites this paper as Halle et al, 2008
In the citing paper
“In particular, microglial NLRP3 has been shown to be a major driver of amyloid beta and tau toxicity in AD, suggesting its activation has important implications for disease progression (Halle et al, 2008; Venegas et al, 2017; Ising et al, 2019).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Halle et al, 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,992
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Flagged first, then by citations
3 of the 50 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 1,015
Cellular Stress Response and Immune Signaling in Retinal Ischemia–Reperfusion Injury
Minhas, G., Sharma, J. N., & Khan, N. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00444 · Cited by 135
Liu, X., Pichulik, T., Wolz, O., Dang, T., Stutz, A., Dillen, C. A., Garcia, M. D., Kraus, H., Dickhöfer, S., Daiber, E., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.017 · Cited by 137
Self-citationInflammasomes as therapeutic targets for A lzheimer's disease
White, C., Lawrence, C. B., Brough, D., & Rivers‐Auty, J. (2016) · Brain Pathology · doi:10.1111/bpa.12478 · Cited by 136
Langley, M. R., Ghosh, A., Charli, A., Sarkar, S., Ay, M., Luo, J. D., Zielonka, J., Brenza, T. M., Bennett, B., Jin, H., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6905 · Cited by 128
Periprosthetic osteolysis: Characterizing the innate immune response to titanium wear‐particles
Pierre, C. A. S., Chan, M., Iwakura, Y., Ayers, D. C., Kurt‐Jones, E. A., & Finberg, R. W. (2010) · Journal of Orthopaedic Research® · doi:10.1002/jor.21149 · Cited by 130
Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease
Welch, G., & Tsai, L. (2022) · The EMBO Reports · doi:10.15252/embr.202154217 · Cited by 129
Hirota, K., Hasegawa, T., Nakajima, T., Inagawa, H., Kohchi, C., Soma, G., Makino, K., & Terada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.020 · Cited by 130
Cai, S., Batra, S., Wakamatsu, N., Pacher, P., & Jeyaseelan, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200195 · Cited by 131
Modulation of three key innate immune pathways for the most common retinal degenerative diseases
Akhtar‐Schäfer, I., Wang, L., Krohne, T. U., Xu, H., & Langmann, T. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708259 · Cited by 129
Zhong, X., Liu, M., Yao, W., Du, K., He, M., Jin, X., Jiao, L., Ma, G., Wei, B., & Wei, M. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801230 · Cited by 129
Eitel, J., Meixenberger, K., Suttorp, N., & Opitz, B. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-05-0323 · Cited by 133
Unsolved Mysteries in NLR Biology
Lupfer, C. R., & Kanneganti, T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00285 · Cited by 130
Uromodulin Triggers IL-1β–Dependent Innate Immunity via the NLRP3 Inflammasome
Darisipudi, M. N., Thomasová, D., Mulay, S. R., Brech, D., Noeßner, E., Liapis, H., & Anders, H. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040338 · Cited by 129
Danger Signals in the Initiation of the Inflammatory Response after Myocardial Infarction
de Haan, J. J., Smeets, M. B., Pasterkamp, G., & Arslan, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/206039 · Cited by 139
Rosales‐Corral, S., Tan, D., Manchester, L. C., & Reiter, R. J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/985845 · Cited by 134
Yun, H.-M., Kim, H. S., Kr, P., Shin, J., Kang, A.-R., Lee, K. I., Song, S., Kim, Y.-B., Han, S., Chung, H.-M., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.490 · Cited by 128
Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1 β Production
Tőzsér, J., & Benkő, S. (2016) · Mediators of Inflammation · doi:10.1155/2016/5460302 · Cited by 129
NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease
Zhang, Y., Dong, Z., & Song, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0145-7 · Cited by 128
α‐Synuclein evokes NLRP3 inflammasome‐mediated IL ‐1β secretion from primary human microglia
Pike, A. F., Varanita, T., Herrebout, M. A. C., Plug, B. C., Kole, J., Musters, R. J. P., Teunissen, C. E., Hoozemans, J. J. M., Bubacco, L., & Veerhuis, R. (2021) · Glia · doi:10.1002/glia.23970 · Cited by 136
IL-1 family cytokines in inflammation and immunity
Garlanda, C., Ceglie, I. D., & Jaillon, S. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01358-8 · Cited by 153
Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs
Peeters, P. M., Eurlings, I. M. J., Perkins, T. N., Wouters, E. F. �., Schins, R. P. F., Borm, P. J. A., Drommer, W., Reynaert, N. L., & Albrecht, C. (2014) · Particle and Fibre Toxicology · doi:10.1186/s12989-014-0058-0 · Cited by 134
Intracellular sensing of microbes and danger signals by the inflammasomes
Horvath, G. L., Schrum, J. E., Nardo, C. M. D., & Latz, E. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01050.x · Cited by 127
Self-citationInoue, M., & Shinohara, M. L. (2013) · Autoimmune Diseases · doi:10.1155/2013/859145 · Cited by 123
Adaptive immunity after cell death
Zelenay, S., & Sousa, C. R. E. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.005 · Cited by 129
Tonkin, R. S., Bowles, C., Perera, C. J., Keating, B. A., Makker, P. G. S., Duffy, S. S., Lees, J. G., Tran, C., Don, A. S., Fath, T., et al. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.016 · Cited by 124
Principles of inflammasome priming and inhibition: implications for psychiatric disorders
Herman, F. J., & Pasinetti, G. M. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.06.010 · Cited by 115
Gicquel, T., Robert, S., Loyer, P., Victoni, T., Bodin, A., Ribault, C., Gléonnec, F., Couillin, I., Boichot, E., & Lagente, V. (2015) · The FASEB Journal · doi:10.1096/fj.14-267393 · Cited by 133
Toll-Like Receptor 2 and NLRP3 Cooperate To Recognize a Functional Bacterial Amyloid, Curli
Rapsinski, G. J., Wynosky-Dolfi, M. A., Oppong, G. O., Tursi, S. A., Wilson, R. P., Brodsky, I. E., & Tükel, Ç. (2014) · Infection and Immunity · doi:10.1128/iai.02370-14 · Cited by 127
An, N., Gao, Y., Si, Z., Zhang, H., Wang, L., Tian, C., Yuan, M., Yang, X., Li, X., Shang, H., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01592 · Cited by 124
Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer’s Disease
Zhang, Y., Zhao, Y., Zhang, J., & Yang, G. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03121-z · Cited by 127
Microglia in Alzheimer’s Disease in the Context of Tau Pathology
Perea, J. R., Bolós, M., & Ávila, J. (2020) · Biomolecules · doi:10.3390/biom10101439 · Cited by 134
Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation
Xu, Z., Chen, Z.-M., Wu, X., Zhang, L., Cao, Y., & Zhou, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609441 · Cited by 127
Interleukin-1β in Central Nervous System Injury and Repair.
Hewett, S. J., Jackman, N. A., & Claycomb, R. (2012) · PubMed · Cited by 121
Aguzzi, A., & Zhu, C. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90605 · Cited by 122
Ambiguities in NLRP3 inflammasome regulation: Is there a role for mitochondria?
Lawlor, K. E., & Vince, J. E. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.08.014 · Cited by 124
Ahmed, M. E., Iyer, S. S., Thangavel, R., Kempuraj, D., Selvakumar, G. P., Raikwar, S. P., Zaheer, S. A., & Zaheer, A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170634 · Cited by 120
Inflammatory mechanisms in neurodegeneration
Nichols, M. R., St‐Pierre, M., Wendeln, A., Makoni, N. J., Gouwens, L. K., Garrad, E. C., Sohrabi, M., Neher, J. J., Tremblay, M., & Combs, C. K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14674 · Cited by 129
Paasila, P. J., Davies, D., Kril, J. J., Goldsbury, C. S., & Sutherland, G. T. (2019) · Brain Pathology · doi:10.1111/bpa.12717 · Cited by 120
Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver
Ganz, M. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i43.4772 · Cited by 122
Rashidi, M., Simpson, D. S., Hempel, A., Frank, D. O., Petrie, E. J., Vince, A. J., Feltham, R., Murphy, J., Chatfield, S. M., Salvesen, G. S., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900228 · Cited by 120
25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner
Wong, M. Y., Lewis, M., Doherty, J. J., Shi, Y., Cashikar, A. G., Amelianchik, A., Tymchuk, S., Sullivan, P. M., Qian, M., Covey, D. F., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01869-3 · Cited by 121
NLRP3 inflammasome signalling in Alzheimer's disease
McManus, R. M., & Latz, E. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109941 · Cited by 136
Self-citationThe NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
Benetti, E., Chiazza, F., Patel, N. S. A., & Collino, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/678627 · Cited by 122
Lack of the Nlrp3 Inflammasome Improves Mice Recovery Following Traumatic Brain Injury
Irrera, N., Pizzino, G., Calò, M., Pallio, G., Mannino, F., Famà, F., Arcoraci, V., Fodale, V., David, A., Francesca, C., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00459 · Cited by 120
The Roles of Endoplasmic Reticulum in NLRP3 Inflammasome Activation
Zhou, Y., Tong, Z., Jiang, S., Zheng, W., Zhao, J., & Zhou, X. (2020) · Cells · doi:10.3390/cells9051219 · Cited by 125
A Critical Role for Human Caspase-4 in Endotoxin Sensitivity
Kajiwara, Y., Schiff, T., Voloudakis, G., Sosa, M. A. G., Elder, G. A., Bozdagi, O., & Buxbaum, J. D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303424 · Cited by 119
Xu, Q., Zhao, B., Ye, Y., Li, Y., Zhang, Y., Xiong, X., & Gu, L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02137-8 · Cited by 119
Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer’s disease pathology
Cheng, J., Dong, Y., Ma, J., Pan, R., Liao, Y., Kong, X., Li, X., Li, S., Chen, P.-F., Wang, L., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe3600 · Cited by 121
Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y. T., Yu, B., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02567-y · Cited by 127
Ni, J., Wu, Z., Peterts, C., Yamamoto, K., Qing, H., & Nakanishi, H. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1599-15.2015 · Cited by 118
Mukhopadhyay, S., Varin, A., Chen, Y., Liu, B., Tryggvason, K., & Gordon, S. (2010) · Blood · doi:10.1182/blood-2010-03-276733 · Cited by 119
Shimada, K., Crother, T. R., Karlin, J. N., Chen, S., Chiba, N., Ramanujan, V. K., Vergnes, L., Ojcius, D. M., & Arditi, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021477 · Cited by 120
Tzeng, T.-C. J., Schattgen, S., Monks, B. G., Wang, D., Cerny, A., Latz, E., Fitzgerald, K. A., & Golenbock, D. T. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.011 · Cited by 125
Self-citationYi, B., Sahn, J. J., Ardestani, P. M., Evans, A. K., Scott, L. L., Chan, J. Z., Iyer, S., Crisp, A., Zuniga, G., Pierce, J. T., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13917 · Cited by 116
Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats
Mawhinney, L. J., Vaccari, J. P. D. R., Dale, G. A., Keane, R. W., & Bramlett, H. M. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-123 · Cited by 118
Bryan, N. B., Dorfleutner, A., Kramer, S. J., Yun, C., Rojanasakul, Y., & Stehlik, C. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-23 · Cited by 123
Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson’s disease
Sarkar, S., Nguyen, H. M., Malovic, E., Luo, J. D., Langley, M. R., Palanisamy, B. N., Singh, N., Manne, S., Neal, M. P., Gabrielle, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136174 · Cited by 118
Inflammasomes as molecular mediators of inflammation and cancer: Potential role in melanoma
Dunn, J. H., Ellis, L. Z., & Fujita, M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.001 · Cited by 117
Kim, S. (2022) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2022.29.3.140 · Cited by 124
Shi, J., Zhang, C., Sun, X., Cheng, X., Wang, J., Zhang, Y., Xu, J. L., & Zou, H. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12066 · Cited by 116
Li, X., Zhang, Y., Xia, M., Gulbins, E., Boini, K. M., & Li, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087552 · Cited by 116
Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9
Tursi, S. A., Lee, E. Y., Medeiros, N. J., Lee, M. H., Nicastro, L. K., Buttaro, B., Gallucci, S., Wilson, R. P., Wong, G. C. L., & Tükel, Ç. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006315 · Cited by 115
This old heart: Cardiac aging and autophagy
Linton, P., Gurney, M. A., Sengstock, D. M., Mentzer, R. M., & Gottlieb, R. A. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.12.017 · Cited by 115
Nicolson, G. L., & Ash, M. E. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.11.010 · Cited by 117
A Role for the Adaptor Proteins TRAM and TRIF in Toll-like Receptor 2 Signaling
Nilsen, N. J., Vladimer, G. I., Stenvik, J., Ørning, P., Zeid-Kilani, M. V., Bugge, M., Bergstrøm, B., Conlon, J. E., Husebye, H., Hise, A. G., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.593426 · Cited by 114
Self-citationRubio‐Araiz, A., Finucane, O. M., Keogh, S., & Lynch, M. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1281-7 · Cited by 117
Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases
Seok, J. K., Kang, H. C., Cho, Y., Lee, H. S., & Lee, J. Y. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01307-9 · Cited by 122
NLRP inflammasomes in health and disease
Xu, Z., Kombe, A. J. K., Deng, S., Zhang, H., Wu, S., Ruan, J., Zhou, Y. Y., & Jin, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00179-x · Cited by 131
Woodling, N. S., Wang, Q., Priyam, P. G., Larkin, P. B., Shi, J., Johansson, J. U., Zagol-Ikapitte, I. A., Boutaud, O. G., & Andreasson, K. I. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0410-14.2014 · Cited by 117
Li, L., Ismael, S., Nasoohi, S., Sakata, K., Liao, F., McDonald, M. P., & Ishrat, T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180814 · Cited by 117
la Fuente, M. D., Franchi, L., Araya, D. V., Díaz-Jiménez, D., Olivares, M., Álvarez-Lobos, M., Golenbock, D. T., González, M., López-Köstner, F., Quera, R., et al. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.01.002 · Cited by 113
Self-citationWang, Y., Han, Z., Fan, Y., Zhang, J., Chen, K., Gao, L., Zeng, H., Cao, J., & Wang, C. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000470822 · Cited by 113
Markham, A., Bains, R. S., Franklin, P., & Spedding, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12531 · Cited by 113
Compan, V., Martín‐Sánchez, F., Baroja‐Mazo, A., López‐Castejón, G., Gomez, A. I., Verkhratsky, A., Brough, D., & Pelegrı́n, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1301676 · Cited by 116
Chen, L., Na, R., Boldt, E., & Ran, Q. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.018 · Cited by 112
Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis
Wang, Y., Gao, B., & Xiong, S. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00441.2014 · Cited by 109
An Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to Pathology
Ratsimandresy, R. A., Dorfleutner, A., & Stehlik, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00440 · Cited by 114
TRPM2 dependence of ROS-induced NLRP3 activation in Alzheimer's disease
Aminzadeh, M., Roghani, M., Sarfallah, A., & Riazi, G. H. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.10.024 · Cited by 110
Nakanishi, A., Kaneko, N., Takeda, H., Sawasaki, T., Morikawa, S., Zhou, W., Kurata, M., Yamamoto, T., Akbar, S. M. F., Zako, T., et al. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0085-6 · Cited by 115
Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation
Yabal, M., Calleja, D. J., Simpson, D. S., & Lawlor, K. E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-124r · Cited by 110
Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification
Wen, C., Yang, X., Yan, Z., Zhao, M., Yue, X., Cheng, X., Zheng, Z., Guan, K., Dou, J., Xu, T., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.211 · Cited by 110
Olsen, I., & Yilmaz, Ö. (2016) · Journal of Oral Microbiology · doi:10.3402/jom.v8.30385 · Cited by 112
Zinc depletion regulates the processing and secretion of IL-1β
Summersgill, H. R., England, H., López‐Castejón, G., Lawrence, C. B., Luheshi, N., Pahle, J., Mendes, P., & Brough, D. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.547 · Cited by 112
Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model
Sil, A., Erfani, A., Lamb, N., Copland, R., Riedel, G., & Platt, B. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-210523 · Cited by 109
NLRP3 inflammasome: The rising star in cardiovascular diseases
Zheng, Y., Li, X., Dong, N., & Li, F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.927061 · Cited by 122
Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
Hernández‐Pedro, N., Espinosa-Ramírez, G., de la Cruz, V. P., Pineda, B., & Sotelo, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/413465 · Cited by 113
Mizunoe, Y., Sudo, Y., Okita, N., Hiraoka, H., Mikami, K., Narahara, T., Negishi, A., Yoshida, M., Higashibata, R., Watanabe, S., et al. (2017) · Autophagy · doi:10.1080/15548627.2016.1274850 · Cited by 111
Feng, J., Wang, J., Du, Y., Liu, Y., Zhang, W., Chen, J., Liu, Y., Zheng, M., Wang, K., & He, G. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12983 · Cited by 107
Viroporins and inflammasomes: A key to understand virus-induced inflammation
Farag, N. S., Breitinger, U., Breitinger, H., & Azizi, M. A. E. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105738 · Cited by 107
Inflammation and Alzheimer’s Disease: Mechanisms and Therapeutic Implications by Natural Products
Rather, M. A., Khan, A., Alshahrani, S., Rashid, H., Qadri, M. M., Rashid, S., Alsaffar, R. M., Kamal, M. A., & Rehman, M. U. (2021) · Mediators of Inflammation · doi:10.1155/2021/9982954 · Cited by 114
Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
Wang, Q., Yao, H., Liu, W., Ya, B., Cheng, H., Xing, Z., & Wu, Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.772717 · Cited by 111
The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation
Shi, F., Yang, L., Kouadir, M., Yang, Y., Wang, J., Zhou, X., Yin, X., & Zhao, D. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-73 · Cited by 112
The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
Doty, K. R., Guillot-Sestier, M.-V., & Town, T. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.008 · Cited by 104
Xia, M., Boini, K. M., Abais, J. M., Xu, M., Zhang, Y., & Li, P.-L. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.01.032 · Cited by 106
A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity
Champion, C. I., Kickhoefer, V. A., Liu, G., Moniz, R. J., Freed, A. S., Bergmann, L. L., Vaccari, D., Raval-Fernandes, S., Chan, A. M., Rome, L. H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005409 · Cited by 106
The intra‐ and extracellular functions of ASC specks
Franklin, B. S., Latz, E., & Schmidt, F. I. (2017) · Immunological Reviews · doi:10.1111/imr.12611 · Cited by 112
Self-citationSwaroop, S., Mahadevan, A., Shankar, S. K., Adlakha, Y. K., & Basu, A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1214-5 · Cited by 107
Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110
Cathepsin B Degrades Amyloid-β in Mice Expressing Wild-type Human Amyloid Precursor Protein
Wang, C., Sun, B., Zhou, Y., GRUBB, A. O., & Gan, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371641 · Cited by 112
Li, T., Lu, L., Pember, E., Li, X., Zhang, B., & Zhu, Z. (2022) · Cells · doi:10.3390/cells11121925 · Cited by 109
Metadata
- Authors
- Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- University of Freiburg (DE)
- Corresponding author
- Golenbock, Douglas T
- ORCID
- Venue
- Nature Immunology
- Published
- 2008-07-11
- Volume
- 9
- Issue
- 8
- Pages
- 857-865
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3101478
- OpenAlex
- W2119098586
- Cited by
- 2,441
- References
- 50
- Citations by year
- 2026: 92 · 2025: 124 · 2024: 143 · 2023: 165 · 2022: 191 · 2021: 188 · 2020: 169 · 2019: 151 · 2018: 136 · 2017: 139 · 2016: 138 · 2015: 146 · 2014: 149 · 2013: 153 · 2012: 98
- FWCI
- 35.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@UMassChan (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- National Institute on Aging (R01AG020255, AG20255)
- National Institute of General Medical Sciences (R37GM054060, R01GM054060, GM 54060)
- National Institute of Allergy and Infectious Diseases (AI065483, R01AI065483)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- NLRP3 inflammasome, amyloid-beta, Alzheimer's disease, innate immunity, IL-1β, caspase-1, microglia, phagocytosis, lysosomal damage, cathepsin B, neuroinflammation, neurotoxicity
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Carrier Proteins, Immunity, Innate, Inflammation, Amyloid beta-Peptides, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
